Michael Thiele
Chief Scientific Officer OncoOne
Seminars
Wednesday 12th November 2025
Introducing a Tumour Agnostic Pre-Targeted Radiotherapeutic Platform to Target Tumour Associated Macrophages
11:30 am
- Pretargeting to increase therapeutic windows in RLTs
- OncoOne’s Pretarg-it® platform
- Data from preclinical tumor models and outlook
